SUSGO LTD

Company number 14026337 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SUSGO LTD - Analysis Report

Company Number: 14026337

Analysis Date: 2025-07-29 20:43 UTC

Financial Health Assessment for SUSGO LTD


1. Financial Health Score: D

Explanation: SUSGO LTD is currently showing significant financial distress, with persistent negative net assets ("equity") over the last three reported years and large current liabilities exceeding current assets by a wide margin. Although there was some improvement in cash balances in the latest year, the company remains financially unhealthy, reflecting symptoms akin to a patient struggling with a chronic condition that requires urgent intervention.


2. Key Vital Signs: Critical Metrics and Their Interpretation

Metric 2025 (£) Interpretation
Fixed Assets 113 Minimal investment in long-term assets, indicating low capital intensity or early-stage operation.
Current Assets 2,060 Very low short-term asset base, primarily cash and debtors.
Cash 1,522 Cash on hand increased from prior year, indicating some improvement in liquidity.
Debtors 538 Small amount of money owed by customers; manageable but could impact cash flow if delayed.
Current Liabilities 128,814 Extremely high short-term debts owed within one year, a major red flag for liquidity crisis.
Net Current Assets -126,754 Negative working capital, meaning liabilities greatly exceed current assets — a serious symptom.
Net Assets (Equity) -126,641 Company’s total liabilities exceed assets by over £126k; technically insolvent on the balance sheet.
Shareholders’ Funds -126,642 Mirrors the negative net assets, showing accumulated losses or funding shortfall.

3. Diagnosis: What the Financial Data Reveals About Business Health

  • Liquidity Crisis: The company is experiencing severe liquidity distress, with current liabilities nearly 62 times greater than cash available. This suggests an inability to meet short-term obligations without external funding or restructuring.

  • Balance Sheet Insolvency: The negative net assets position over several years indicates the company’s liabilities surpass its assets, a classic symptom of financial distress or insolvency risk.

  • Operational Scale and Capital Structure: Very low fixed assets and minimal employee count (1 employee) suggest a small-scale operation, possibly in early growth or struggling phase. The called-up share capital is nominal (£1), indicating limited equity buffer.

  • Improvement Signal: The increase in cash from £651 in 2024 to £1,522 in 2025 shows some positive cash flow management or capital injection, but this is insufficient relative to liabilities.

  • Director and Control Changes: One director and secretary resigned in 2024; two directors remain. Control is concentrated between two individuals owning 75-100%, which could both facilitate quick decision-making and risk lack of diverse oversight.

  • Industry Context: Operating in "Other information technology service activities" (SIC 62090), which may require agility and investment to remain competitive; current financial health may hinder this.


4. Recommendations: Specific Actions to Improve Financial Wellness

  1. Urgent Cash Flow Management:

    • Develop a detailed cash flow forecast.
    • Prioritize collection of outstanding debts and reduce discretionary spending.
    • Negotiate extended payment terms with creditors to relieve short-term pressure.
  2. Capital Restructuring:

    • Consider equity injection from existing or new shareholders to shore up net assets.
    • Explore debt restructuring options or refinancing to extend maturities.
  3. Cost Optimization:

    • Review operational expenses critically; consider downsizing or streamlining processes.
    • Evaluate the necessity of fixed asset holdings and reduce overhead where possible.
  4. Strategic Review and Growth Planning:

    • Assess market positioning and identify new revenue streams or clients.
    • Invest cautiously in business development with clear ROI.
  5. Governance and Oversight:

    • Strengthen board oversight, possibly adding independent advisors.
    • Ensure compliance and transparency to build stakeholder confidence.
  6. Prepare for Insolvency Contingencies:

    • Given the severity of financial distress, have a contingency plan including professional insolvency advice to avoid unexpected closure.

Medical Analogy Summary: SUSGO LTD is showing "symptoms of financial distress" akin to a patient with a serious illness marked by negative net worth and liquidity shortfalls. While some "vital signs" (cash increase) suggest tentative recovery, the overall picture requires immediate "treatment" via cash management, capital restructuring, and strategic intervention to prevent progression to insolvency.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.